Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-034779
Filing Date
2012-06-20
Accepted
2012-06-20 18:52:19
Documents
1
Period of Report
2012-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 43527
  Complete submission text file 0001209191-12-034779.txt   44969
Mailing Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121 858-652-6500
Ardea Biosciences, Inc./DE (Issuer) CIK: 0001103390 (see all company filings)

EIN.: 943200380 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address
TANG KEVIN C (Reporting) CIK: 0001178579 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33734 | Film No.: 12918179